TMates vs Maximus: Price, doctor access, and availability compared
Quick verdict: For patients prioritizing 24/7 access to U.S.-based doctors and a flat price at every dose choose TMates; for those prioritizing lower monthly cost and simple telemedicine fulfillment choose Maximus. This TMates vs Maximus comparison highlights the most distinctive differences so you can decide quickly.
Compare TMates pricing and access
Price and pricing model
Price is the clearest divide in the TMates vs Maximus comparison. TMates lists a flat $199/month at every dose, including the company statement “$199/month, every dose, no step-up fees” and provides tiered multi-month options on its pages. Maximus positions itself as lower cost with a $132.99/month flat rate and mentions starter offers “starting at “$79.99” in some placements and free priority shipping.
Doctor access and clinical oversight
Both platforms route prescriptions through clinicians, but they emphasize different models. TMates advertises 24/7 access to U.S.-based doctors and virtual check-in appointments for ongoing medical oversight. Maximus emphasizes licensed doctor approvals via telemedicine and convenient online care with no clinic visits. These are both clinician-reviewed telehealth models, but TMates highlights continuous physician availability rather than messaging-only support.
What that means for patients
If ongoing around-the-clock physician access matters to you TMates is explicit about 24/7 U.S.-based doctor availability. If you want a lower monthly expense and a straightforward telemedicine path to a prescription Maximus focuses on licensed doctor approvals and convenient online visits.
See how Maximus telemedicine works
Medication sourcing and formulation
Both TMates and Maximus provide compounded semaglutide formulated in U.S.-based facilities or filled through U.S. pharmacies. TMates states “Meds formulated in the USA | Clinically Dosed Compounded Semaglutide” and notes medications are formulated in U.S.-based facilities. Maximus says prescriptions are filled through trusted U.S. pharmacies. Both include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Availability and shipping
TMates indicates licensed coverage in all 50 states and that it “ships to most states” with program availability based on medical eligibility. Maximus specifies availability in all 50 states except Mississippi and offers free expedited or priority shipping in some listings. If state availability is decisive check each platform for your state and eligibility because TMates and Maximus both condition treatment on medical review.
Program features and limitations
TMates frames its product as a full-service GLP-1 program with virtual check-ins and a flat rate that does not increase with dose. Maximus frames its program as low-cost and simple with telemedicine-only visits and prescriptions approved by licensed doctors. Both focus on compounded semaglutide rather than branded finished products and both warn the medication is compounded, not an FDA-approved finished product.
| Criteria | TMates | Maximus |
|---|---|---|
| Monthly price | $199/month flat at every dose | $132.99/month (advertised) |
| Doctor access | 24/7 U.S.-based doctors and virtual check-ins | Licensed doctors via telemedicine, no clinic visits |
| Medication sourcing | Formulated in U.S.-based facilities | Filled through trusted U.S. pharmacies |
| State availability | Licensed coverage in all 50 states; ships to most states | Available in all 50 states except Mississippi |
| Compounded status | Compounded semaglutide; not FDA-approved finished product | Compounded semaglutide; not FDA-approved finished product |
Patient experience and best fit
TMates is best for patients who value continuous physician availability and a predictable flat-rate that does not increase during titration. Maximus is best for patients who prioritize a lower monthly price and a compact telemedicine process with U.S. pharmacy fulfillment. Public outcome data, long term track record comparisons, and tirzepatide availability are not detailed in the supplied sources and are therefore not addressed here.
Review TMates clinical and pricing details
Safety, regulatory note, and refunds
Both providers include the regulatory caveat that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Maximus states that if you are not approved for treatment your medication costs will be fully refunded. TMates notes availability is based on medical eligibility and advises following provider guidance for dose resumption and adjustments.
Check Maximus availability and refund policy
Conclusion: TMates vs Maximus
In the TMates vs Maximus comparison the major trade offs are price versus access. TMates charges $199/month flat at every dose and emphasizes 24/7 U.S. doctor access and virtual check-ins. Maximus offers a lower $132.99/month rate, telemedicine approvals, and U.S. pharmacy fulfillment with availability in most states except Mississippi. Both use compounded semaglutide and both require clinician review and medical eligibility.
Choose TMates if you want continuous 24/7 access to U.S.-based doctors and a flat $199/month price that does not increase as dose escalates. Choose Maximus if your priority is a lower monthly cost ($132.99/month advertised) with licensed doctor approvals via telemedicine and fulfillment through U.S. pharmacies.